Digital Health Startups

OU Health is Oklahoma's comprehensive academic health system partnered with the University of Oklahoma, operating hospitals, clinics, and centers of excellence that serve patients across Oklahoma and the region. The organization operates over 11,000 employees including more than 1,300 physicians, managing specialized facilities including a children's hospital, an NCI-designated cancer center, and a Level I trauma center.

1 investor

OK Positive offers an AI-driven digital platform that centralizes mental health and wellbeing content, resources, events, and services into a single hub, with real-time analytics on user engagement, mood, and support outcomes. It serves organisations' HR teams, charities and councils, and UK and overseas universities supporting employees, service users, and students.

1 investor

Olaqin provides payment solutions tailored for pharmacies and laboratories, enabling patients to pay by card and automating transaction processing while maintaining compliance with healthcare sector requirements.

1 investor

Olea Medical is a French medical imaging company focused on software for the post-processing and analysis of MRI and CT scan data, intended for use by healthcare professionals. The site is restricted to healthcare professionals under French health-sector regulations.

1 investor

Olfactive Biosolutions develops Pivit, a product platform that applies receptor science to consumer food and beverage products by translating natural food molecules into targeted physiological outcomes.

1 investor

Olivo Sciences licenses de-identified multimodal patient data (multi-omics, imaging, clinical, and wearable) and provides domain-trained AI models for biopharma companies across the drug development cycle, with a focus on brain and neurological disorders. It supports target discovery, clinical trial design and enrollment, and post-marketing real-world evidence generation.

1 investor

MetLife's Gulf regional operation offers insurance and financial products for individuals and businesses, with tools for managing policies and tracking health. It serves customers in the Gulf/Middle East region.

1 investor

Omanta provides personalized scientific research support for complex disease cases, assigning PhD-level teams to build detailed molecular profiles from a patient's genomic, RNA, and protein data. It cross-references each patient's molecular profile against an internal reference cohort and biomedical literature to model therapeutic options and produce a research roadmap that informs the clinical team's decisions.</parameter> <parameter name="founders">[]

1 investor

Omedus Tech develops Triage360, a wireless automated triage system that continuously monitors and prioritizes patients in real time for first responders, medics, and ER technicians. The product supports faster, better-informed triage decisions during emergency and crisis care.

1 investor

Datma provides a federated data collaboration platform connecting health systems and labs with pharmaceutical companies for secure access to real-world clinical and molecular data. The platform enables pharma teams to access complete, de-identified datasets while allowing health systems and labs to maintain data control and generate revenue.

1 investor

Ommej offers a mobile app that lets children tell their own story about how they feel and are doing in different areas of life, along with an administration tool that gives organizations access to a child's account. It serves child-welfare and support services (including integration with the Backa Barnet model) to help adults understand a child's perspective and provide earlier, preventive support.

1 investor

Omni Biotech develops hardware-agnostic algorithms that read optical (PPG) signals from existing smartwatches to continuously monitor hydration, heat strain and fatigue against each wearer's own baseline. It launches first for mining, construction and resources crews working in extreme heat in Western Australia, with additional applications in sports, defense, first responders and clinical/aged care, and licenses its digital biomarkers to consumer wearable brands.</parameter> <parameter name="founders">[]

1 investor

Omni AI is an AI-powered practice management and revenue cycle management platform for specialty physician practices, using AI agents to automate front-end administrative work such as benefit verification and prior authorization. It integrates with a practice's EMR, practice management, and clearinghouse systems, including custom connections to local HMO plans, to reduce claim denials and improve collections.

1 investor

OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.

1 investor

Omnicare is a German healthcare group focused on oncology, operating medical care centers (MVZ) with physicians and oncologists across multiple sites, clean-room laboratories, pharmaceutical wholesale, hygiene monitoring, and quality initiatives for pharmacies and oncology practices. It also runs psychosomatic clinics and provides software (eApo) and training for medical staff.

1 investor

Omnivers is a clinical care platform that consolidates patient data and tools—including task management, billing dashboards, telehealth, and remote patient monitoring—into a single interface for healthcare facilities. It integrates with systems such as PointClickCare, Matrix, and Sigma to help caregivers manage visits, documentation, and revenue.

1 investor

Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.

1 investor

ONCALL operates a home medical care support service in Japan, providing night and holiday house-call teams plus an online "Connect" team that supports clinical decisions and links medical institutions and multidisciplinary staff nationwide. It aims to expand young physicians' involvement in home care and improve the quality and supply of home-based medical care, particularly end-of-life care.

1 investor

Ona provides an AI phone agent for healthcare clinics and practices that answers calls 24/7, books appointments into live calendars, captures patient intake data into charts, and routes complex calls to humans. It serves solo to enterprise medical practices across primary care, behavioral health, physical therapy, and specialty care.

1 investor

Oncare provides cancer treatment with structured, transparent surgery packages, dedicated care coordinators, and end-to-end insurance/cashless paperwork handling. It serves cancer patients in India, drawing on senior oncology specialists trained at institutions such as AIIMS and Tata Memorial Hospital.

1 investor

Oncobit provides molecular diagnostic solutions that enable clinicians to monitor cancer and optimize therapy selection through advanced genetic analysis of plasma samples.

1 investor

Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.

1 investor

Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.

1 investor

OncoForma develops a functional precision oncology platform that tests patient-derived tumor organoids against comprehensive drug panels to predict treatment efficacy before therapy begins. The company serves oncologists and cancer patients in the global oncology market, operating from Saskatchewan with a pathway to scale from fee-for-service testing to AI-enabled predictive medicine.

1 investor